AZI2

AZI2 (NAP1) is a TBK1 adaptor protein that couples the kinase TBK1 to inflammatory, autophagic, and cell-death signaling complexes, thereby shaping innate immune output and immune cell development (PMID:23610142, PMID:39562788). At the TNF receptor signaling complex, AZI2 is recruited later than TANK via the deubiquitinase A20 to deliver TBK1 and suppress TNF-induced RIPK1-dependent cell death; combined loss of TANK and AZI2 produces severe autoinflammation that is rescued by TNFR1 deficiency or kinase-dead RIPK1 (PMID:39562788). In antiviral signaling, AZI2 promotes type I interferon production by facilitating TBK1–TANK interactions, and its loss worsens influenza pathology (PMID:35595469). AZI2 also operates at selective autophagy machinery: it accumulates with cargo receptors upon RB1CC1/FIP200 depletion to activate TBK1 and drive a DDX3X–IRF3 pro-inflammatory program that promotes CD8+ T cell infiltration (PMID:32580962, PMID:37733921), and it is recruited to damaged mitochondria where it is phosphorylated at S318 and required specifically for NDP52-driven, but not OPTN-driven, mitophagy (PMID:39276928). Beyond TBK1-centered functions, AZI2 restrains osteoclast survival by inhibiting c-Src activity through interaction with the Hsp90 co-chaperone Cdc37, and its loss causes severe osteoporosis reversible by c-Src inhibition (PMID:25691576).

1. 2013 High

   Established AZI2 as a physiologically required factor for dendritic cell development, linking it to TBK1-dependent control of GM-CSF-induced cell cycling and downstream T cell activation.

   Evidence AZI2 knockout mice, bone marrow differentiation assays, and overexpression with in vitro/in vivo T cell activation readouts

   PMID:23610142

   Open questions at the time

   • Did not resolve the molecular interface between AZI2 and TBK1 in this context
   • Mechanism connecting TBK1 to GM-CSF cell-cycle control not defined
2. 2015 High

   Revealed a TBK1-independent role for AZI2 in skeletal homeostasis, showing it limits osteoclast survival by suppressing c-Src through the Hsp90 co-chaperone Cdc37.

   Evidence AZI2 knockout mice with osteoporosis phenotype, c-Src activity assays, Hsp90/Cdc37 interaction studies, and c-Src inhibitor rescue

   PMID:25691576

   Open questions at the time

   • Direct biochemical nature of the AZI2-Cdc37 interaction not structurally defined
   • Whether this function intersects with AZI2's TBK1 adaptor role is unaddressed
3. 2020 Medium

   Connected AZI2 to a non-canonical autophagy axis by showing FIP200 binds AZI2 and that FIP200 loss triggers AZI2-dependent TBK1/IFN activation with consequences for antitumor immunity.

   Evidence Co-immunoprecipitation of FIP200-AZI2, FIP200-ablation mouse models, and TBK1/IFN pathway readouts in breast cancer

   PMID:32580962

   Open questions at the time

   • Single-lab interaction data without broader structural mapping
   • How FIP200 normally restrains AZI2-TBK1 activation is not mechanistically resolved
4. 2022 Medium

   Defined how AZI2 drives antiviral interferon output, showing it promotes TBK1-TANK association during influenza infection to support type I IFN production and host survival.

   Evidence AZI2 knockout mice in an influenza lung model, immunoprecipitation, immunofluorescence, and luciferase reporter assays

   PMID:35595469

   Open questions at the time

   • Single-lab study; reciprocal validation of TBK1-TANK bridging is limited
   • Whether AZI2 directly stabilizes the TBK1-TANK complex versus indirectly is unclear
5. 2023 Medium

   Extended the autophagy-inflammation link by showing AZI2 accumulates at stalled cargo-receptor complexes to activate TBK1 and a DDX3X-IRF3 transcriptional program promoting CD8+ T cell infiltration.

   Evidence RB1CC1 depletion, AZI2 puncta imaging, AZI2-DDX3X-IRF3 co-IP, chemokine assays, pharmacological screen, and tumor T cell measurements

   PMID:37733921

   Open questions at the time

   • Single-lab data; the trigger for AZI2 puncta accumulation is not fully defined
   • Direct versus indirect DDX3X engagement not biochemically separated
6. 2024 Medium

   Placed AZI2 in selective mitophagy, demonstrating it is recruited to damaged mitochondria and phosphorylated at S318 to support NDP52-driven but not OPTN-driven degradation.

   Evidence AZI2/TBKBP1 and OPTN knockout constructs, mitophagy assays, and S318 phosphosite mutagenesis with recruitment imaging

   PMID:39276928

   Open questions at the time

   • Kinase responsible for S318 phosphorylation not identified
   • S318 mutation only slightly impairs degradation, leaving its functional weight uncertain
7. 2024 High

   Resolved how AZI2 and TANK cooperate at the TNF receptor complex, showing distinct recruitment routes (TANK via NEMO early, AZI2 via A20 later) that jointly suppress RIPK1-dependent cell death.

   Evidence Single and double knockout mice, TNFR1-deficiency and kinase-dead RIPK1 rescues, and interaction mapping of TANK-NEMO and AZI2-A20

   PMID:39562788

   Open questions at the time

   • Structural basis of the AZI2-A20 interaction not defined
   • How AZI2-delivered TBK1 mechanistically restrains RIPK1 not fully detailed

• It remains unresolved how AZI2's distinct functions — TBK1 adaptor activity across TNFR, antiviral, and autophagy contexts versus Cdc37/Hsp90-mediated c-Src regulation — are integrated or differentially deployed across cell types.
• No structural model of AZI2 domains assigning regions to TBK1 versus Cdc37 binding
• Regulatory logic selecting between AZI2's pro-survival and pro-death/pro-inflammatory roles unknown